Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Analysis of 10 independent samples provides evidence for association between schizophrenia and a SNP flanking fibroblast growth factor receptor 2

O'Donovan, Michael Conlon, Norton, Nadine, Williams, Hywel John, Peirce, Timothy Rowan, Escott-Price, Valentina, Nikolov, Ivan, Hamshere, Marian Lindsay, Carroll, Liam Stuart, Georgieva, Lyudmila, Dwyer, Sarah Lynne, Holmans, Peter Alan, Marchini, J. L., Spencer, C. C. A., Howie, B., Leung, H.T., Giegling, I., Hartmann, A. M., Möller, H.J., Morris, D. W., Shi, Y., Feng, G., Hoffmann, P., Propping, P., Vasilescu, C., Maier, W., Rietschel, M., Zammit, Stanley, Schumacher, J., Quinn, E. M., Schulze, T. G., Iwata, N., Ikeda, M., Darvasi, A., Shifman, S., He, L., Duan, J., Sanders, A. R., Levinson, D. F., Adolfsson, R., Ösby, U., Terenius, L, Jönsson, E. G., Cichon, S., Nöthen, M. M., Gill, M., Corvin, A. P., Rujescu, D., Gejman, P. V., Kirov, George, Craddock, Nicholas John, Williams, Nigel Melville and Owen, Michael John 2009. Analysis of 10 independent samples provides evidence for association between schizophrenia and a SNP flanking fibroblast growth factor receptor 2. Molecular Psychiatry 14 (1) , pp. 30-36. 10.1038/mp.2008.108

Full text not available from this repository.

Abstract

We and others have previously reported linkage to schizophrenia on chromosome 10q25–q26 but, to date, a susceptibility gene in the region has not been identified. We examined data from 3606 single-nucleotide polymorphisms (SNPs) mapping to 10q25–q26 that had been typed in a genome-wide association study (GWAS) of schizophrenia (479 UK cases/2937 controls). SNPs with P<0.01 (n=40) were genotyped in an additional 163 UK cases and those markers that remained nominally significant at P<0.01 (n=22) were genotyped in replication samples from Ireland, Germany and Bulgaria consisting of a total of 1664 cases with schizophrenia and 3541 controls. Only one SNP, rs17101921, was nominally significant after meta-analyses across the replication samples and this was genotyped in an additional six samples from the United States/Australia, Germany, China, Japan, Israel and Sweden (n=5142 cases/6561 controls). Across all replication samples, the allele at rs17101921 that was associated in the GWAS showed evidence for association independent of the original data (OR 1.17 (95% CI 1.06–1.29), P=0.0009). The SNP maps 85 kb from the nearest gene encoding fibroblast growth factor receptor 2 (FGFR2) making this a potential susceptibility gene for schizophrenia.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Neuroscience and Mental Health Research Institute (NMHRI)
Medicine
MRC Centre for Neuropsychiatric Genetics and Genomics (CNGG)
Systems Immunity Research Institute (SIURI)
Subjects: R Medicine > RC Internal medicine > RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry
Uncontrolled Keywords: FGFR2; schizophrenia; genome-wide association study FGFR2; schizophrenia; genome-wide association study
Publisher: Nature Publishing Group
ISSN: 1359-4184
Last Modified: 08 Aug 2019 20:20
URI: http://orca.cf.ac.uk/id/eprint/27689

Citation Data

Cited 61 times in Google Scholar. View in Google Scholar

Cited 51 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item